Helen Tayton-Martin - Chief Business & Strgy Officer at Adaptimmune Therapeutics PLC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business & Strgy Officer
Issuer Symbol
ADAPY on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Helen Tayton-Martin since 11 Mar 2025

Holdings reported by Helen Tayton-Martin for Adaptimmune Therapeutics PLC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Option to purchase Ordinary Shares 565,416 15 Jan 2024 Direct Ordinary Shares

Transactions reported by Helen Tayton-Martin for Adaptimmune Therapeutics PLC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.